LeonaBio, Inc. (LONA) Income Statement
LONA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsLONA revenue and net income
LONA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
LONA quarterly EPS vs estimates
LeonaBio beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 5, 2026 (estimate $-0.62).
LONA income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $68.1M | — | — | — | $479,000 | $2.0M | — | — |
| Gross profit | −$68.1M | — | — | — | −$479,000 | −$2.0M | — | — |
| Research & development | $17.5M | $70.7M | $93.8M | $61.5M | $42.8M | $13.3M | $3.8M | $3.6M |
| Sales, general & admin | $16.7M | $26.1M | $33.3M | $32.6M | $21.2M | $6.7M | $1.7M | $1.4M |
| Total operating expenses | $34.2M | $100.9M | $125.5M | $104.0M | $63.5M | $18.0M | $4.7M | $5.0M |
| Operating income | −$102.3M | −$100.9M | −$125.5M | −$104.0M | −$64.0M | −$20.0M | −$5.4M | −$5.0M |
| Interest income | — | — | — | — | $337,000 | — | — | — |
| Interest expense | — | — | — | $24.3M | $3,000 | $367,000 | $346,000 | $9,000 |
| Income before taxes | −$105.6M | −$96.9M | −$117.7M | −$95.6M | −$54.9M | −$20.0M | −$5.2M | −$5.1M |
| Net income | −$105.6M | −$96.9M | −$117.7M | −$95.6M | −$54.9M | −$20.0M | −$5.2M | −$5.1M |
| EBITDA | −$33.2M | −$95.8M | −$126.0M | −$88.0M | −$54.4M | −$19.6M | −$4.8M | −$79,000 |
| EPS (diluted) | −$23.08 | −$21.78 | −$30.90 | −$18.19 | −$10.94 | −$11.88 | −$1.58 | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $227,000 | $231,000 | $68.1M | $243,000 | $200,000 | $243,000 | — | — | $242,000 | $242,000 | — | — |
| Gross profit | −$227,000 | −$231,000 | −$68.1M | −$243,000 | −$200,000 | −$243,000 | — | — | −$242,000 | −$242,000 | — | — |
| Research & development | $12.7M | $11.3M | $6.7M | $2.6M | $3.7M | $4.3M | $9.4M | $17.9M | $21.9M | $21.0M | $23.7M | $27.2M |
| Sales, general & admin | $6.6M | $6.9M | $3.8M | $4.0M | $3.6M | $5.2M | $6.2M | $7.6M | $5.9M | $6.5M | $7.0M | $7.8M |
| Total operating expenses | $19.5M | $17.9M | $10.5M | $6.6M | $7.1M | $9.3M | $15.6M | $29.6M | $27.8M | $27.4M | $29.0M | $35.0M |
| Operating income | −$19.5M | −$18.1M | −$78.6M | −$6.9M | −$7.3M | −$9.5M | −$15.6M | −$29.6M | −$28.0M | −$27.7M | −$29.0M | −$35.0M |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $1.9M | — |
| Income before taxes | −$19.0M | −$32.9M | −$82.9M | −$6.6M | −$7.0M | −$9.1M | −$15.0M | −$28.7M | −$26.9M | −$26.3M | −$27.3M | −$33.0M |
| Net income | −$19.0M | −$32.9M | −$82.9M | −$6.6M | −$7.0M | −$9.1M | −$15.0M | −$28.7M | −$26.9M | −$26.3M | −$27.3M | −$33.0M |
| EBITDA | −$18.8M | −$17.9M | −$10.2M | −$6.4M | −$6.8M | −$8.9M | −$15.3M | −$25.3M | −$27.8M | −$27.4M | −$30.4M | −$34.8M |
| EPS (diluted) | −$0.80 | −$1.73 | −$18.92 | −$1.68 | −$0.18 | −$2.30 | −$0.38 | −$7.50 | −$7.00 | −$6.90 | −$7.10 | −$8.70 |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LONA's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
LONA financial results
LeonaBio reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $105.6 million. Diluted earnings per share came to −$23.08.
See the LONA stock overview for the latest quote and news, or the LONA chart for price history and technical indicators.
LONA income statement FAQ
Does LeonaBio have revenue?
LeonaBio reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is LeonaBio profitable?
No. LeonaBio reported a net loss of $105.6 million in fiscal 2025.
How much does LeonaBio spend on research and development?
LeonaBio spent $17.5 million on research and development in fiscal 2025.
What are LeonaBio's earnings per share?
LeonaBio earned $-23.08 per diluted share in fiscal 2025, compared with $-21.78 a year earlier.
When will LeonaBio report its next earnings?
LeonaBio is expected to report results for the quarter ending September 30, 2026 on November 5, 2026.
When does LeonaBio's fiscal year end?
LeonaBio's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 31, 2026.